U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Childhood Favorable Prognosis Hodgkin Lymphoma

MedGen UID:
859257
•Concept ID:
C3899663
•
Neoplastic Process

Definition

A Hodgkin lymphoma with favorable prognosis that occurs during childhood. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVChildhood Favorable Prognosis Hodgkin Lymphoma

Professional guidelines

PubMed

Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
Attarbaschi A, Carraro E, Ronceray L, Andrés M, Barzilai-Birenboim S, Bomken S, Brugières L, Burkhardt B, Ceppi F, Chiang AKS, Csoka M, Fedorova A, Jazbec J, Kabickova E, Loeffen J, Mellgren K, Miakova N, Moser O, Osumi T, Pourtsidis A, Rigaud C, Uyttebroeck A, Woessmann W, Pillon M; European Intergroup for Childhood Non-Hodgkin’s Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group
Leukemia 2021 Feb;35(2):534-549. Epub 2020 May 11 doi: 10.1038/s41375-020-0841-x. PMID: 32393843
Assessment of tumor Epstein-Barr Virus status and its impact on outcomes in intermediate and high-risk childhood classic Hodgkin Lymphoma treated at a tertiary cancer center in India.
Cheriyalinkal Parambil B, Narula G, Dhamne C, Roy Moulik N, Shet T, Shridhar E, Gujral S, Shah S, Laskar S, Khanna N, Banavali S
Leuk Lymphoma 2020 Dec;61(13):3217-3225. Epub 2020 Jul 30 doi: 10.1080/10428194.2020.1800005. PMID: 32729791
Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.
Végso G, Hajdu M, Sebestyén A
Pathol Oncol Res 2011 Sep;17(3):443-54. Epub 2010 Dec 31 doi: 10.1007/s12253-010-9329-8. PMID: 21193979

Recent clinical studies

Etiology

Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
Attarbaschi A, Carraro E, Ronceray L, Andrés M, Barzilai-Birenboim S, Bomken S, Brugières L, Burkhardt B, Ceppi F, Chiang AKS, Csoka M, Fedorova A, Jazbec J, Kabickova E, Loeffen J, Mellgren K, Miakova N, Moser O, Osumi T, Pourtsidis A, Rigaud C, Uyttebroeck A, Woessmann W, Pillon M; European Intergroup for Childhood Non-Hodgkin’s Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group
Leukemia 2021 Feb;35(2):534-549. Epub 2020 May 11 doi: 10.1038/s41375-020-0841-x. PMID: 32393843
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.
Davis KL, Fox E, Merchant MS, Reid JM, Kudgus RA, Liu X, Minard CG, Voss S, Berg SL, Weigel BJ, Mackall CL
Lancet Oncol 2020 Apr;21(4):541-550. Epub 2020 Mar 17 doi: 10.1016/S1470-2045(20)30023-1. PMID: 32192573Free PMC Article
Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk-adapted approach in a tertiary cancer center in India.
Parambil BC, Narula G, Prasad M, Shah S, Shet T, Shridhar E, Khanna N, Laskar S, Gujral S, Sankaran H, Banavali S
Pediatr Blood Cancer 2020 Feb;67(2):e28058. Epub 2019 Nov 13 doi: 10.1002/pbc.28058. PMID: 31724304
Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
Hodgson DC, Hudson MM, Constine LS
Semin Radiat Oncol 2007 Jul;17(3):230-42. doi: 10.1016/j.semradonc.2007.02.009. PMID: 17591570
Lymphoblastic leukaemia and non-Hodgkin's lymphoma.
Lilleyman JS, Pinkerton CR
Br Med Bull 1996 Oct;52(4):742-63. doi: 10.1093/oxfordjournals.bmb.a011580. PMID: 9039729

Diagnosis

Overall and event-free survival of childhood lymphoma in Greece: analysis of harmonized clinical data over a 24-year active registration period.
Karalexi MA, Pourtsidis A, Panagopoulou P, Moschovi M, Polychronopoulou S, Kourti M, Hatzipantelis E, Stiakaki E, Dana H; NARECHEM-ST collaborating group, Bouka P, Ntzani EE, Petridou ET
Leuk Lymphoma 2021 Sep;62(9):2107-2119. Epub 2021 Jun 11 doi: 10.1080/10428194.2021.1907376. PMID: 34114936
Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
Attarbaschi A, Carraro E, Ronceray L, Andrés M, Barzilai-Birenboim S, Bomken S, Brugières L, Burkhardt B, Ceppi F, Chiang AKS, Csoka M, Fedorova A, Jazbec J, Kabickova E, Loeffen J, Mellgren K, Miakova N, Moser O, Osumi T, Pourtsidis A, Rigaud C, Uyttebroeck A, Woessmann W, Pillon M; European Intergroup for Childhood Non-Hodgkin’s Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group
Leukemia 2021 Feb;35(2):534-549. Epub 2020 May 11 doi: 10.1038/s41375-020-0841-x. PMID: 32393843
Parenthood in adult female survivors treated for Hodgkin's lymphoma during childhood and adolescence: a prospective, longitudinal study.
Brämswig JH, Riepenhausen M, Schellong G
Lancet Oncol 2015 Jun;16(6):667-75. Epub 2015 May 7 doi: 10.1016/S1470-2045(15)70140-3. PMID: 25959806
Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.
Végso G, Hajdu M, Sebestyén A
Pathol Oncol Res 2011 Sep;17(3):443-54. Epub 2010 Dec 31 doi: 10.1007/s12253-010-9329-8. PMID: 21193979
Secondary non-Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL.
Landmann E, Oschlies I, Zimmermann M, Moser O, Graf N, Suttorp M, Greiner J, Reiter A; Berlin-Frankfurt-Münster group
Br J Haematol 2008 Nov;143(3):387-94. Epub 2008 Aug 20 doi: 10.1111/j.1365-2141.2008.07356.x. PMID: 18729852

Therapy

Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
Attarbaschi A, Carraro E, Ronceray L, Andrés M, Barzilai-Birenboim S, Bomken S, Brugières L, Burkhardt B, Ceppi F, Chiang AKS, Csoka M, Fedorova A, Jazbec J, Kabickova E, Loeffen J, Mellgren K, Miakova N, Moser O, Osumi T, Pourtsidis A, Rigaud C, Uyttebroeck A, Woessmann W, Pillon M; European Intergroup for Childhood Non-Hodgkin’s Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group
Leukemia 2021 Feb;35(2):534-549. Epub 2020 May 11 doi: 10.1038/s41375-020-0841-x. PMID: 32393843
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.
Davis KL, Fox E, Merchant MS, Reid JM, Kudgus RA, Liu X, Minard CG, Voss S, Berg SL, Weigel BJ, Mackall CL
Lancet Oncol 2020 Apr;21(4):541-550. Epub 2020 Mar 17 doi: 10.1016/S1470-2045(20)30023-1. PMID: 32192573Free PMC Article
Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk-adapted approach in a tertiary cancer center in India.
Parambil BC, Narula G, Prasad M, Shah S, Shet T, Shridhar E, Khanna N, Laskar S, Gujral S, Sankaran H, Banavali S
Pediatr Blood Cancer 2020 Feb;67(2):e28058. Epub 2019 Nov 13 doi: 10.1002/pbc.28058. PMID: 31724304
Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
Hodgson DC, Hudson MM, Constine LS
Semin Radiat Oncol 2007 Jul;17(3):230-42. doi: 10.1016/j.semradonc.2007.02.009. PMID: 17591570
The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G
Ann Oncol 1996;7 Suppl 4:67-72. doi: 10.1093/annonc/7.suppl_4.s67. PMID: 8836413

Prognosis

Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
Attarbaschi A, Carraro E, Ronceray L, Andrés M, Barzilai-Birenboim S, Bomken S, Brugières L, Burkhardt B, Ceppi F, Chiang AKS, Csoka M, Fedorova A, Jazbec J, Kabickova E, Loeffen J, Mellgren K, Miakova N, Moser O, Osumi T, Pourtsidis A, Rigaud C, Uyttebroeck A, Woessmann W, Pillon M; European Intergroup for Childhood Non-Hodgkin’s Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group
Leukemia 2021 Feb;35(2):534-549. Epub 2020 May 11 doi: 10.1038/s41375-020-0841-x. PMID: 32393843
Assessment of tumor Epstein-Barr Virus status and its impact on outcomes in intermediate and high-risk childhood classic Hodgkin Lymphoma treated at a tertiary cancer center in India.
Cheriyalinkal Parambil B, Narula G, Dhamne C, Roy Moulik N, Shet T, Shridhar E, Gujral S, Shah S, Laskar S, Khanna N, Banavali S
Leuk Lymphoma 2020 Dec;61(13):3217-3225. Epub 2020 Jul 30 doi: 10.1080/10428194.2020.1800005. PMID: 32729791
Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk-adapted approach in a tertiary cancer center in India.
Parambil BC, Narula G, Prasad M, Shah S, Shet T, Shridhar E, Khanna N, Laskar S, Gujral S, Sankaran H, Banavali S
Pediatr Blood Cancer 2020 Feb;67(2):e28058. Epub 2019 Nov 13 doi: 10.1002/pbc.28058. PMID: 31724304
Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
Hodgson DC, Hudson MM, Constine LS
Semin Radiat Oncol 2007 Jul;17(3):230-42. doi: 10.1016/j.semradonc.2007.02.009. PMID: 17591570
Lymphoblastic leukaemia and non-Hodgkin's lymphoma.
Lilleyman JS, Pinkerton CR
Br Med Bull 1996 Oct;52(4):742-63. doi: 10.1093/oxfordjournals.bmb.a011580. PMID: 9039729

Clinical prediction guides

Overall and event-free survival of childhood lymphoma in Greece: analysis of harmonized clinical data over a 24-year active registration period.
Karalexi MA, Pourtsidis A, Panagopoulou P, Moschovi M, Polychronopoulou S, Kourti M, Hatzipantelis E, Stiakaki E, Dana H; NARECHEM-ST collaborating group, Bouka P, Ntzani EE, Petridou ET
Leuk Lymphoma 2021 Sep;62(9):2107-2119. Epub 2021 Jun 11 doi: 10.1080/10428194.2021.1907376. PMID: 34114936
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.
Davis KL, Fox E, Merchant MS, Reid JM, Kudgus RA, Liu X, Minard CG, Voss S, Berg SL, Weigel BJ, Mackall CL
Lancet Oncol 2020 Apr;21(4):541-550. Epub 2020 Mar 17 doi: 10.1016/S1470-2045(20)30023-1. PMID: 32192573Free PMC Article
Parenthood in adult female survivors treated for Hodgkin's lymphoma during childhood and adolescence: a prospective, longitudinal study.
Brämswig JH, Riepenhausen M, Schellong G
Lancet Oncol 2015 Jun;16(6):667-75. Epub 2015 May 7 doi: 10.1016/S1470-2045(15)70140-3. PMID: 25959806
Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
Hodgson DC, Hudson MM, Constine LS
Semin Radiat Oncol 2007 Jul;17(3):230-42. doi: 10.1016/j.semradonc.2007.02.009. PMID: 17591570
The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G
Ann Oncol 1996;7 Suppl 4:67-72. doi: 10.1093/annonc/7.suppl_4.s67. PMID: 8836413

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...